+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease



Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease



Cancer Treatment Reports 68(7-8): 947-951



Thirty-nine patients with advanced Hodgkin's disease were treated with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). Thirty-one of these patients had previously failed to respond to MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) treatment (29 patients) or to CCVPP (lomustine, cyclophosphamide, vincristine, procarbazine, and prednisone) treatment (two patients). Twenty-seven patients were considered evaluable: eight (30%) achieved complete remission (CR), two (7%) achieved partial remission (PR), and 17 (63%) had no response. All of the complete responders are still in continuous unmaintained CR, while 14 of the 19 partial responders and nonresponders have died. The overall median survival was 21 months; it was 16 months for partial responders and nonresponders. The remaining eight patients had ABVD substituted to MOPP early in treatment, because of allergy to procarbazine: six patients achieved CR and two achieved PR. Our results are in keeping with the literature data and confirm the effectiveness of ABVD as primary and salvage treatment in advanced Hodgkin's disease.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042855939

Download citation: RISBibTeXText

PMID: 6204754


Related references

Doxorubicin bleomycin vinblastine and dacarbazine salvage of mechlorethamine vincristine prednisone and procarbazine resistant advanced hodgkins disease. Cancer Treatment Reports 68(7-8): 947-952, 1984

Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy. Medical and Pediatric Oncology 29(1): 23-27, 1997

Alternating Combination Chemotherapy C-Mopp (Cyclophosphamide, Vincristine, Procarbazine, Prednisone) and Abvd (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) in Clinical Stage Ii-Iv Hodgkin's Disease: a Multicenter Phase Ii Study (Jcog 8905). Japanese Journal of Clinical Oncology 30(3): 146-152, 2000

Gonadal toxicity after combination chemotherapy for hodgkins disease comparative results of mopp mechlorethamine vincristine procarbazine and prednisone vs. adriamycin bleomycin vinblastine and dacarbazine. European Journal of Cancer and Clinical Oncology 21(5): 601-606, 1985

Chemotherapy of hodgkin's lymphoma with alternating cycles of copp cyclophosphamide vincristine procarbazine prednisone and abvd doxorubicin bleomycin vinblastine and dacarbazine results of the hd1 and hd3 trials of the german hodgkin study group. Medical Oncology and Tumor Pharmacotherapy 6(2): 155-162, 1989

Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Cancer 88(9): 2142-2148, 2000

Treatment of mechlorethamine vincristine procarbazine prednisone resistant hodgkins disease with adriamycin bleomycin vinblastine and dacarbazine. European Journal of Cancer & Clinical Oncology 18(9): 803-806, 1982

Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Cancer Treatment Reports 67(5): 413-419, 1983

Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group. Cancer Treatment Reports 71(12): 1203-1207, 1987

Chlorambucil vinblastine procarbazine and prednisone ch1vpp an effective but less toxic regimen than mopp mechlorethamine vincristine prednisone procarbazine for advanced stage hodgkin's disease. Proceedings of the American Association for Cancer Research Annual Meeting 27: 198, 1986

Cyclic delivery of mechlorethamine vincristine procarbazine prednisone and doxorubicin bleomycin vinblastine dacarbazine combinations in stage iv hodgkins disease rationale background studies and recent results. Cancer Treatment Reports 66(4): 881-888, 1982

Salvage chemo therapy with adriamycin bleomycin vinblastine daunomycin in mechlorethamine vincristine procarbazine prednisone resistant hodgkins disease. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 22: 522, 1981

Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group. Japanese Journal of Clinical Oncology 30(3): 146-152, 2000

Efficacy of lomustine, teniposide, doxorubicin, bleomycin and prednisone (LTABP) or adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) in the treatment of malignant lymphogranulomatosis resistant to MOPP. Polski Tygodnik Lekarski 45(21-22): 426-429, 1990

Mechlorethamine, Vincristine, Procarbazine, and Prednisone (MOPP) Regimen for Advanced Hodgkin's Disease. Hospital Pharmacy 36(10): 1026-1032, 2001